Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 71

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 71
---
 of Year of Outstanding and Unvested Equity Awards Granted in any Prior Year for Non-PEO NEOs 
                                                                                                                                                               ($) |     | Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs 
 ($)                                                                                                           |     | Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards Granted in any Prior Year that Vested During Year for Non-PEO NEOs 
                                                                                                                                                                   ($) |     | Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs 
                                                                                                  ($) |     | Total - Average Inclusion of Equity Values for Non-PEO NEOs 
                                                         ($) |
| 2024 |     |                                                                                                                                       1,444,680 |     |                                                                                                                                                          -323,542 |     | —                                                                                                             |     |                                                                                                                                                                54,381 |     |                                                                                             -415,803 |     |                                                     759,716 |

(4) The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2024. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the Nasdaq Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.

Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return, or TSR

The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average Compensation Actually Paid to our Non-PEO NEOs, and the Company’s cumulative TSR over the four most recently completed fiscal years and the Nasdaq Biotechnology Index TSR over the same period.

<div align='center'>54</div>

Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income

The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average Compensation Actually Paid to our Non-PEO NEOs, and our net income during the four most recently completed fiscal years.

<div align='center'>55</div>

#### Stock Option and Other Compensation Plans
The two equity incentive plans described in this section are the 2018 Plan and the 2018 ESPP. We